Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your Body Mass Index (BMI) is between 25 and 40 (a measure of body weight relative to height that indicates overweight or obesity range)
- You have not done any regular exercise training for at least the past year
- You have not followed any special diet or eating plan in the last 6 months
- Your cardiovascular fitness level is relatively low, meaning your body's ability to use oxygen during exercise is below a certain threshold (confirm with trial site for exact measurement)
- You are not currently taking any medications or dietary supplements
- You are considered low risk for heart or blood vessel disease
- You have not lost more than 10% of your body weight in the last 6 months
- You are generally free from long-term illnesses, though having metabolic syndrome (a group of conditions like high blood pressure and high blood sugar together) does not automatically exclude you
Who may not be able to join:
- You attend fewer than 80% of the required exercise sessions during the trial
- You are following an unbalanced or irregular diet
- You are taking part in any other exercise programme outside of this trial
- You are taking anti-inflammatory medications or pain relief drugs (such as ibuprofen or similar)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in mitochondrial size; Change in mitochondrial density; Change in mitochondrial count; Change in mitochondrial distribution; Change in maximum oxygen consumption (VO2max); Change in muscle fiber cross-sectional area; Change in PAX7+ satellite cells count; Change in total protein content; Change in myonuclei content; Change in peroxisome proliferator-activated receptor-gamma coactivator -1a (PGC-1a) expression; Change in Krebs cycle (TCA cycle) enzymes activity; Change in protein expression of respiratory chain complexes; Change in cytochrome C oxidase amount and expression; Change in AT...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.